Missed it live? The ALKtALK replay with Dr. Alex Drilon is now available.
Learn about new data and emerging directions for neladalkib (NVL-655) and how precision oncology continues to shape treatment for ALK-positive lung cancer.
🎥 Watch the replay:
youtu.be/PRrfLmIQb9I?...
Join ALKtALK this Sunday:
New Data, New Directions: Neladalkib (NVL-655) & Precision Oncology in ALK+ Cancer
Featuring Alexander Drilon, MD (MSK)
🧬 Latest clinical data
🔬 How trials move toward access
🧪 Biomarker-driven insights
💬 Live Q&A
📅 March 1, 2026
🕖 7 PM ET
Today is National Care Partner Day, to all those supporting loved ones with ALK-positive cancer — your strength and love carry more than most will ever know.
We are deeply grateful.
Join our next Care Partner Check-In
Feb 26 @ 9PM ET
alkpositive.org/events/categ...
🎥 Clinical Trials Connect Recording Now Available
youtube.com/playlist?lis...
Missed it live? Watch our Clinical Trials Connect session with Jeff Sturm, Dr. Ken Culver, Sadia Yaakov, and ALK Positive Medical Committee members.
Learn what clinical trials mean for ALK-positive patients—now or later.
We’re at TTLC 2026 in Huntington Beach, CA!
Targeted Therapies of Lung Cancer focuses on breakthrough targeted treatments, resistance research, and the future of precision care. We're here to stay close to the science, build partnerships, and advance progress in ALK+ research.
This Sunday at 7pm ET 💙
tALKing about Treatments: An ALKtALK Roundtable for ALK-positive patients & care partners.
Connect. Share. Learn from others who truly get it.
No medical advice — just real conversation and community.
Join us: alkpositive.org/event/alktal...
See you there!
ALK+ community,
Join us tonight at 7pm ET for a Healing Arts discussion on clinical trials with Jeff Sturm, Dr. Ken Culver, and Sadia Yaakov.
A patient-centered space to ask questions, learn what to expect, and explore your options with clarity and support.
See you there!
An ALK diagnosis can turn your world upside down. In this community, we learn how to turn it downside up—finding people who understand the scans, the waiting, and the hope.
This #WorldCancerDay, we celebrate our ALK family. 💙
#UnitedByUnique #LungCancer #Community
13 years after a stage IV ALK+ lung cancer diagnosis at age 15, Jake Legasse is not just living, but thriving—and even running marathons. Learn how Jake thinks about mindset and copes with uncertainty—and his advice to people with ALK+. alkpositive.org/blog/patient...
In this clip from Cancer Nurses Today, Dr. Ken Culver shares how nurses help people with lung cancer navigate treatment and decisions.
At ALK Positive Inc., we support those conversations so our community is never left to figure it out alone.
✨ Together, we did something extraordinary. ✨
Thanks to our community, donors, partners, and advocates, we raised $3.5M+ in 2025 to support ALK-positive patients and families worldwide.
Every gift fuels hope, research, and connection.
From the bottom of our hearts—thank you. 💙
#Grateful
🌟 Watch Our First ALKtALK of 2026!
Watch the recording of world-renowned thoracic oncologist Dr. Alice Shaw, the “Queen of ALK,” as she shares the latest in ALK-positive lung cancer research and what it could mean for future treatment. youtu.be/Au-DrJ4WAq0?...
What does progress look like for the ALK-positive community?
At #ESMO25, Dr. Ken Culver shared how ALK Positive Inc. advocates for people living with ALK+ lung cancer—bringing science, real-world patient insight, and unmet needs directly to industry and researchers.
💙 We’re feeling the love.
In-person tickets for the 2026 ALK+ Summit are sold out.
You can still join the waitlist or attend live virtually — with real-time Q&As, interactive chats, and chances to win prizes, all from wherever you are.
secure.qgiv.com/for/2026alks...
Meet Sara J. 💙
A facilitator of our Multilingual Chat / Charla Multilingüe, a welcoming space for patients & caregivers worldwide—where language is never a barrier to belonging.
📅 Jan 13, 3 PM ET
🔗 Link in bio
#StrongerTogether
👑 Dr. Alice Shaw returns to ALKtALK
🗓 Sunday, Jan 11, 2026 | 7pm ET
A global leader in ALK-positive research, Dr. Shaw shares the latest science—including an emerging MTAP deletion clinical trial—and what it could mean for future treatment.
💬 Live Q&A
We're honored to see ALK Positive’s grant supporting Dr. Alice Shaw’s research at Dana-Farber featured in Dana-Farber Impact Magazine. Funding MTAP research in ALK+ lung cancer to drive better outcomes for patients worldwide.
📖 alkpositive.org/blog/alk-pos...
📣 Only 18 in-person tickets left for the 2026 ALK+ Summit!
Once those are gone, we’ll move to the waitlist and continue welcoming everyone to join us live virtually. Joining us virtually is free and includes live sessions, Q&As, interactive moments, and prize opportunities. We hope you can join us
Booking your trip to the 2026 ALK Positive Summit? ✈️
Use Health Care Fares to save on flights and give back — they donate $10 to ALK Positive for every ticket booked.
👉 Book here: healthcarefares.com/en
#ALKPositive #ALKSummit #GiveBack
2026 ALK+ Summit registration is open!
Join us July 24–26 in Washington, D.C. (or virtually) to learn from ALK-experienced physicians and researchers, take part in live Q&As, and connect with the ALK-positive community.
Register now: secure.qgiv.com/for/2026alks...
They’re still here — 10+ years later.
This moment was made possible by donors like you. Right now, every gift is matched through Dec. 31 to fund research, education, and support.
Help us reach our annual goal.
secure.qgiv.com/for/alkposit...
🚨 $10,000 MATCH CHALLENGE 🚨
Every donation made before December 31 is DOUBLED.
Your support fuels research, education, and real hope for the ALK-positive community.
✨ Give today. Make it count twice. secure.qgiv.com/for/am-ml/
Now Streaming: ALKtALK Replay 🎥
Jesse Boehm returns to ALKtALK to share new insights and updates on Break Through Cancer’s PowerRD 2 Cure ALK+ Lung TeamLab.
▶️ Watch now on our YouTube channel: youtu.be/Unny-4F9pq8?...
#ALKtALK #ALKPositive #PowerRD2Cure #BreakThroughCancer #MoreResearchMoreTime
🎥 Replay now: Your Holiday Toolkit on ALKtALK available on YouTube
Dr. Karen Schurgin shares honest, compassionate guidance on navigating holiday emotions, setting boundaries, managing expectations, and supporting loved ones while caring for yourself.
When Colin was diagnosed with ALK+ cancer, the odds of reaching 5 years were just 2 in 100. Nearly 10 years later, he’s here because clinical trials made today’s treatments possible.
Trials don’t just help participants. They help all of us.
alkpositive.org/clinical-trials
#MoreResearchMoreTime
Clinical trials are beginning to focus on early-stage ALK+ lung cancer.
Read more to see which trials are open and what they’re studying.
alkpositive.org/blog/clinica...
Now open: an independent medical education grant from Pfizer + ALK Positive supporting people with advanced ALK+ NSCLC and care partners.
Focus: ALK therapy prep, side-effect management & shared decision tools.
Apply by Feb 18, 2026:
alkpositive.org/blog/alk-pos...
If you thought 2025 was special… just wait. 💙
2026 ALK+ Summit registration is opening soon — you're not going to want to miss out on this one.
#ALKSummit
Good news for ALK+ patients: Cigna Healthcare now covers ALUNBRIG® (brigatinib) as of 10/1/25, bringing coverage to ~99% of commercial lives.
Co-pay assistance may be available for eligible patients: www.takedaoncologycopay.com
ALK Positive Inc. is proud to announce the 2025 AACR–ALK Positive Lung Cancer Research Fellowship grantee: Alice Tzeng, MD, PhD (Dana-Farber). Her research explores why resistance to lorlatinib develops—and how we can overcome it to drive more durable treatments.
alkpositive.org/blog/alk-pos...
